Literature DB >> 9814827

Dermatitis herpetiformis: coeliac disease of the skin.

T Reunala.   

Abstract

Dermatitis herpetiformis (DH) is a lifelong, gluten-sensitive, blistering skin disease with pathognomonic immunoglobulin (Ig)A deposits in the papillary dermis. Less than 10% of patients with DH have gastrointestinal symptoms suggestive of coeliac disease, yet they all have gluten-sensitive enteropathy. The rash, too, responds to gluten withdrawal. Therefore, DH provides a unique example of the frequent existence of gastroenterologically 'silent' but dermatologically active coeliac disease. DH and coeliac disease are strictly associated with class II HLA alleles A1*0501 and B1*02 encoding the HLA-DQ2 heterodimer. Coeliac disease segregates in the families of patients with DH, also supporting a shared genetic background. Monozygotic twins, one with DH and the other with coeliac disease, show that environmental, not genetic, factors seem to be responsible for the development of the rash in DH. A clinically silent but immunologically active coeliac disease in the gut could well produce IgA autoantibodies which react also with the connective tissue in the skin. The antigen for deposited IgA and its role, if any, in the blister formation in DH remains, however, to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814827     DOI: 10.3109/07853899809002482

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  13 in total

1.  Celiac sprue: a unique autoimmune disorder.

Authors:  Shadi Rashtak; Eric V Marietta; Joseph A Murray
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

2.  Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis.

Authors:  M T Salmela; S L Pender; T Reunala; T MacDonald; U Saarialho-Kere
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders.

Authors:  C Sategna Guidetti; E Solerio; N Scaglione; G Aimo; G Mengozzi
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

4.  Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease.

Authors:  M Westerholm-Ormio; J Garioch; I Ketola; E Savilahti
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 6.  Celiac disease in the elderly.

Authors:  Shadi Rashtak; Joseph A Murray
Journal:  Gastroenterol Clin North Am       Date:  2009-09       Impact factor: 3.806

7.  Decreased numbers of circulating plasmablasts and differences in IgA1-plasmablast homing to skin in coeliac disease and dermatitis herpetiformis.

Authors:  J M Kantele; E Savilahti; M Westerholm-Ormio; S Pakkanen; H S Arvilommi; T Reunala; A M Kantele
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

Review 8.  Neurological complications of coeliac disease.

Authors:  D S N A Pengiran Tengah; A J Wills; G K T Holmes
Journal:  Postgrad Med J       Date:  2002-07       Impact factor: 2.401

Review 9.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

Review 10.  Immunopathology and molecular diagnosis of autoimmune bullous diseases.

Authors:  Sidonia Mihai; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.